510 related articles for article (PubMed ID: 24895606)
1. Side effects of radiographic contrast media: pathogenesis, risk factors, and prevention.
Andreucci M; Solomon R; Tasanarong A
Biomed Res Int; 2014; 2014():741018. PubMed ID: 24895606
[TBL] [Abstract][Full Text] [Related]
2. Prevention of contrast-induced nephropathy through a knowledge of its pathogenesis and risk factors.
Andreucci M; Faga T; Pisani A; Sabbatini M; Russo D; Michael A
ScientificWorldJournal; 2014; 2014():823169. PubMed ID: 25525625
[TBL] [Abstract][Full Text] [Related]
3. [Contrast-induced nephropathy].
Santos RO; Malvar B; Silva R; Ramalho V; Pessegueiro P; Amoedo M; Aniceto J; Pires C
Acta Med Port; 2011; 24(5):809-20. PubMed ID: 22525634
[TBL] [Abstract][Full Text] [Related]
4. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
CalabrĂ² P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; CalabrĂ² R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
5. Contrast-induced nephropathy: epidemiology and prevention.
Bagshaw SM; Culleton BF
Minerva Cardioangiol; 2006 Feb; 54(1):109-29. PubMed ID: 16467746
[TBL] [Abstract][Full Text] [Related]
6. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
[TBL] [Abstract][Full Text] [Related]
7. [Radiographic contrast nephropathy].
Andreucci M
G Ital Nefrol; 2014; 31(5):. PubMed ID: 25315721
[TBL] [Abstract][Full Text] [Related]
8. Acetylcysteine and contrast media nephropathy.
Tepel M; Zidek W
Curr Opin Nephrol Hypertens; 2002 Sep; 11(5):503-6. PubMed ID: 12187314
[TBL] [Abstract][Full Text] [Related]
9. Reducing the risks for contrast-induced nephropathy.
Stacul F
Cardiovasc Intervent Radiol; 2005; 28 Suppl 2():S12-8. PubMed ID: 16419278
[TBL] [Abstract][Full Text] [Related]
10. [Iodinated contrast agent-induced nephropathy].
Erley C
Radiologe; 2007 Sep; 47(9):761-7. PubMed ID: 17823784
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of contrast-induced nephropathy: a brief review.
Chang CF; Lin CC
J Chin Med Assoc; 2013 Dec; 76(12):673-81. PubMed ID: 24090599
[TBL] [Abstract][Full Text] [Related]
12. Acute kidney injury by radiographic contrast media: pathogenesis and prevention.
Andreucci M; Faga T; Pisani A; Sabbatini M; Michael A
Biomed Res Int; 2014; 2014():362725. PubMed ID: 25197639
[TBL] [Abstract][Full Text] [Related]
13. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012.
Owen RJ; Hiremath S; Myers A; Fraser-Hill M; Barrett BJ
Can Assoc Radiol J; 2014 May; 65(2):96-105. PubMed ID: 24559602
[TBL] [Abstract][Full Text] [Related]
14. Acetylcysteine for radiocontrast nephropathy.
Tepel M; Zidek W
Curr Opin Crit Care; 2001 Dec; 7(6):390-2. PubMed ID: 11805540
[TBL] [Abstract][Full Text] [Related]
15. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease.
Ibrahim TA; El-Mawardy RH; El-Serafy AS; El-Fekky EM
Cardiovasc Revasc Med; 2017; 18(5):315-319. PubMed ID: 28532702
[TBL] [Abstract][Full Text] [Related]
16. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
[TBL] [Abstract][Full Text] [Related]
18. Contrast-induced nephropathy--prevention and risk reduction.
Lameire NH
Nephrol Dial Transplant; 2006 Jun; 21(6):i11-23. PubMed ID: 16723348
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Webb JG; Pate GE; Humphries KH; Buller CE; Shalansky S; Al Shamari A; Sutander A; Williams T; Fox RS; Levin A
Am Heart J; 2004 Sep; 148(3):422-9. PubMed ID: 15389228
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of theophylline in preventing contrast-induced nephropathy after coronary angiographic procedures.
Bilasy ME; Oraby MA; Ismail HM; Maklady FA
J Interv Cardiol; 2012 Aug; 25(4):404-10. PubMed ID: 22612071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]